Home Deuterated Building Blocks 67385-09-5
67385-09-5,MFCD00274335
Catalog No.:AA003EX1

67385-09-5 | tert-Butyl (2-mercaptoethyl)carbamate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$21.00   $15.00
- +
5g
98%
in stock  
$38.00   $27.00
- +
25g
98%
in stock  
$122.00   $86.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003EX1
Chemical Name:
tert-Butyl (2-mercaptoethyl)carbamate
CAS Number:
67385-09-5
Molecular Formula:
C7H15NO2S
Molecular Weight:
177.2645
MDL Number:
MFCD00274335
SMILES:
SCCNC(=O)OC(C)(C)C
Properties
Properties
 
BP:
68 °C0.3 mm Hg(lit.)  
Form:
Liquid  
Refractive Index:
n20/D 1.474(lit.)  
Storage:
Inert atmosphere;2-8℃;  

Computed Properties
 
Complexity:
131  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
4  
XLogP3:
1.2  

Downstream Synthesis Route

[1]Kim,YoungZu;Kim,JaePil[SyntheticCommunications,2002,vol.32,#10,p.1601-1605]

[2]CurrentPatentAssignee:SOOCHOWUNIVERSITY(SUZHOU)-CN103922981,2017,BLocationinpatent:Paragraph0048;0049;0050

[3]Lopez,Susana;Simons,S.Stoney[JournalofMedicinalChemistry,1991,vol.34,#6,p.1762-1767]

[4]CurrentPatentAssignee:QILUPHARMACEUTICALGROUPCOLTD-EP2484678,2012,A1Locationinpatent:Page/Pagecolumn16

[5]CurrentPatentAssignee:QILUPHARMACEUTICALGROUPCOLTD-US2012/208833,2012,A1Locationinpatent:Page/Pagecolumn11

[6]CurrentPatentAssignee:QILUPHARMACEUTICALGROUPCOLTD-CN103304544,2016,BLocationinpatent:Paragraph0109;0110;0111

[7]CurrentPatentAssignee:QILUPHARMACEUTICALGROUPCOLTD-CN103819461,2016,BLocationinpatent:Paragraph0090-0093

[8]CurrentPatentAssignee:QILUPHARMACEUTICALGROUPCOLTD-CN103819462,2017,BLocationinpatent:Paragraph0080-0083

[9]CurrentPatentAssignee:XIANBIRDOMEDICINETECH-CN111518055,2020,ALocationinpatent:Paragraph0058-0062;0093;0100

[10]DeKimpe,NorbertG.;Rocchetti,MariaTeresa[JournalofAgriculturalandFoodChemistry,1998,vol.46,#6,p.2278-2281]

[11]CurrentPatentAssignee:PFIZERINC-US2004/225150,2004,A1Locationinpatent:Page4

[12]CurrentPatentAssignee:PFIZERINC-WO2004/80953,2004,A1Locationinpatent:Page18-19

[13]CurrentPatentAssignee:PFIZERINC-WO2004/80955,2004,A1Locationinpatent:Page18

[14]CurrentPatentAssignee:PFIZERINC-WO2004/80954,2004,A1Locationinpatent:Page20

[15]CurrentPatentAssignee:LEOFONDET;SOCIETEANONYMEDERECHERCHESPOURAPPLICATIONSTHERAPEUTIQUES(SARATH)-US4246262,1981,A

[16]El-Gendy,BahaaEl-DienM.;GhazviniZadeh,EbrahimH.;Sotuyo,AniaC.;Pillai,GirinathG.;Katritzky,AlanR.[ChemicalBiologyandDrugDesign,2013,vol.81,#5,p.577-582]

[17]CurrentPatentAssignee:ABLIVAAB-WO2015/155231,2015,A1Locationinpatent:Page/Pagecolumn62;63

[1]Wang,Yanyan;Fan,Jingwei;Darensbourg,DonaldJ.[AngewandteChemie-InternationalEdition,2015,vol.54,#35,p.10206-10210][Angew.Chem.,2015,vol.127,#35,p.10344-10348,5]

[2]Hossain,Khohinur;Florean,Luca;DelTedesco,Anna;Cattaruzza,Elti;Geppi,Marco;Borsacchi,Silvia;Canton,Patrizia;Benedetti,Alvise;Riello,Pietro;Scarso,Alessandro[Chemistry-AEuropeanJournal,2021,vol.27,#71,p.17941-17951]

[3]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US2015/197493,2015,A1Locationinpatent:Paragraph0648;0649;0650

[4]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US2015/225355,2015,A1Locationinpatent:Paragraph0644

[5]CurrentPatentAssignee:ELUCIDAONCOLOGY-WO2022/93800,2022,A2Locationinpatent:Paragraph00868-00869

[6]Saha,UttamK.;Roy,Rene[JournaloftheChemicalSociety.Chemicalcommunications,1995,#24,p.2571-2574]

[7]Suzuki,Takayoshi;Hisakawa,Shinya;Itoh,Yukihiro;Suzuki,Nobuaki;Takahashi,Katsumasa;Kawahata,Masatoshi;Yamaguchi,Kentaro;Nakagawa,Hidehiko;Miyata,Naoki[BioorganicandMedicinalChemistryLetters,2007,vol.17,#15,p.4208-4212]

[8]CurrentPatentAssignee:MERCK&COINC-WO2016/206101,2016,A1Locationinpatent:Page/Pagecolumn45;46

[9]CurrentPatentAssignee:KOREAINSTITUTEOFSCIENCEANDTECHNOLOGY-KR2018/103401,2018,ALocationinpatent:Paragraph0144;0145;0147;0148

[1]CurrentPatentAssignee:QILUPHARMACEUTICALGROUPCOLTD-EP2484678,2012,A1Locationinpatent:Page/Pagecolumn16

[2]CurrentPatentAssignee:QILUPHARMACEUTICALGROUPCOLTD-US2012/208833,2012,A1Locationinpatent:Page/Pagecolumn11

[3]CurrentPatentAssignee:QILUPHARMACEUTICALGROUPCOLTD-CN103819461,2016,BLocationinpatent:Paragraph0090;0094-0096

[4]CurrentPatentAssignee:QILUPHARMACEUTICALGROUPCOLTD-CN103819462,2017,BLocationinpatent:Paragraph0084-0086

[5]Saha,UttamK.;Roy,Rene[JournaloftheChemicalSociety.Chemicalcommunications,1995,#24,p.2571-2574]

[1]Arisawa,Mieko;Sugata,Chiyoshi;Yamaguchi,Masahiko[TetrahedronLetters,2005,vol.46,#36,p.6097-6099]

[2]Ishikawa,Fumihiro;Haushalter,RobertW.;Burkart,MichaelD.[JournaloftheAmericanChemicalSociety,2012,vol.134,#2,p.769-772]

[3]Ishikawa,Fumihiro;Haushalter,RobertW.;Lee,D.John;Finzel,Kara;Burkart,MichaelD.[JournaloftheAmericanChemicalSociety,2013,vol.135,#24,p.8846-8849]

[4]Englebretsen,DarrenR.;Robillard,GeorgeT.[Tetrahedron,1999,vol.55,#21,p.6623-6634]

67385-09-5    67929-87-7   
3-(2-tert-butoxycarbonylamino-ethylsulfanyl)-5-methoxy-1H-indole-2-carboxylicacidmethylester 

[1]Schlosser,KevinM.;Krasutsky,AlexeiP.;Hamilton,HarrietW.;Reed,JessicaE.;Sexton,Karen[OrganicLetters,2004,vol.6,#5,p.819-821]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:67385-09-5 Molecular Formula|67385-09-5 MDL|67385-09-5 SMILES|67385-09-5 tert-Butyl (2-mercaptoethyl)carbamate